Choroideremia (CHM) is an X-linked retinal degeneration. Affected individuals suffer from nyctalopia during early childhood and progressive loss of peripheral visual field with age. The degeneration is characterized by gradual loss of the RPE, outer retina, and choroid, which gives rise to a characteristic atrophic fundal appearance. It is unclear whether the loss of each layer occurs sequentially due to interdependent cell survival, or independently due to shared defects in the ubiquitously-expressed Rab-escort protein (REP1) encoded by the *CHM* gene. This question is now clinically relevant, because it is important to determine which layer should be the primary target for any potential gene replacement therapy for choroideremia.

Fundus autofluorescence (AF) imaging has shown that RPE degeneration in choroideremia occurs in a centripetal fashion, with early loss of peripheral AF leading to the formation of a residual 'island\' of preserved AF with sharply demarcated scalloped edges, usually centred around the fovea. The island shrinks over time and eventually encroaches on the fovea, which is associated with a sharp decline in visual acuity, generally during the fourth to fifth decade of life (Jolly et al.^[@i1552-5783-57-8-3674-b01]^). Changes in the size of the AF island over time could be used to monitor disease progression. However, it is unclear how alterations in AF, taken as a marker for RPE health, correlate with the state of the adjacent photoreceptors and choroid/choriocapillaris. The primary objective of this study was therefore to assess the relationship between retinal structural changes visible with optical coherence tomography (OCT) and changes in AF in choroideremia. Specifically, we investigated the relationship between outer retina integrity and RPE health at the edges of surviving AF islands in a cohort of 38 CHM patients. We also explored the association between the outer retina and choroidal thickness in CHM. Finally, we evaluated the immediate physical effects of subretinal injection on the delicate outer retina architecture at the transition zone of AF in a cohort of trial participants who underwent gene therapy.^[@i1552-5783-57-8-3674-b02]^ Understanding these mechanisms may help in the future evaluation of retinal function following gene therapy, particularly at the periphery of the surviving island of AF.

Methods {#s2}
=======

This was a retrospective noninterventional image analysis of EDI-OCT and AF images from 39 patients with a clinical and genetic diagnosis of choroideremia at the Oxford Eye Hospital, Oxford, UK. The research was performed as part of an ongoing clinical trial (NCT01461213) approved by the national ethics committee and adhered to the Declaration of Helsinki (2013).

High-resolution spectral-domain OCT was obtained using the Spectralis HRA+OCT system (Heidelberg Engineering GmbH, Heidelberg, Germany) with 37 horizontal volume scans covering 30° × 15° centered over the foveola. Enhanced-depth imaging mode was activated during OCT capture and a simultaneous 30° × 30° infrared confocal SLO image was captured automatically. In the same sitting, a 30° × 30° BluePeak laser fundus AF image was captured using the same optics according to the manufacturer\'s standard operating procedure, including focusing in the red-free reflectance mode and Automated Real-Time ('ART\') alignment of at least eight single images to create a mean image.

Precise point-to-point alignment of corresponding locations between OCT and AF images was performed in the Heidelberg Eye Explorer software (HEYEX; Heidelberg Engineering GmbH) in two ways using the SLO image as an intermediary. HEYEX has a sophisticated in-built image recognition and alignment capability, which allows tracking of eye movements during image acquisition. This function is also available during image analysis when a marker annotating the 30° × 30° SLO image attached to the OCT may be copied and pasted onto the corresponding 30° × 30° AF image using common landmarks as reference points in HEYEX. We confirmed the precision of this method of image alignment using an alternative manual technique. This consisted of choosing two fixed reference points (e.g., small vessel branch points) common to both the SLO and AF images. The distance between the two reference points can be measured precisely on each image using the HEYEX marker tool. The ratio of the two measurements was calculated to generate a mathematical conversion factor. A point of interest on an OCT image is automatically displayed on the linked SLO image as a crosshair in HEYEX. A pair of circles centered at the two reference points could then be drawn on the SLO image under high magnification such that they intersect exactly at the crosshair. The diameters of the circles were automatically displayed by HEYEX and used to calculate the predicted diameters of corresponding circles on the AF image by multiplying through the conversion factor. The intersection of the two circles of predicted diameters drawn on the AF image would then correspond exactly with the point of interest on the OCT.

Six choroideremia patients (aged 35--65 years) underwent gene therapy: 0.6 to 1.0 × 10^10^ genome particles of a recombinant adeno-associated viral vector encoding REP1 (AAV2-REP1) was delivered by pars plana vitrectomy and subretinal injection, as reported previously.^[@i1552-5783-57-8-3674-b02]^ Serial images pre-, 1 month post-, and 6 months postgene therapy were obtained at the same locations using the AutoRescan function of the Spectralis by selecting the baseline image as the reference scan. All outer retinal tubulations (cystic structures) on each B-scan of the OCT were identified and mapped to corresponding positions on the AF image using the point-to-point image alignment technique described above.

Subfoveal choroidal thickness (SFCT) was defined as the distance from the outer border of the RPE to the inner scleral border directly below the foveal dip on EDI-OCT. Subfoveal choroidal thickness was measured in 23 choroideremia patients and 20 aged-matched male patients without significant retinal or choroidal pathology. All subjects had refractions between −5.5 and +5.0 diopters (D). For data analysis, choroideremia patients were further divided into three groups based on foveal outer retinal integrity being preserved, disrupted, or lost on OCT. A Kruskal-Wallis test was performed to assess the significance of any differences between the groups.

Results {#s3}
=======

Correlation Between AF and OCT Morphology {#s3a}
-----------------------------------------

Manual and automated point-to-point alignment between outer retinal morphology on the OCT and the edges of AF islands showed consistent correspondence between the edge of AF and the beginning of an acute decline in outer nuclear layer (ONL) thickness on the OCT, which diminished to zero in a triangular slope over approximately 200 μm ([Fig. 1](#i1552-5783-57-8-3674-f01){ref-type="fig"}). To test the consistency of this observation, image alignment analysis was performed using OCT and AF images from 78 eyes of 39 patients with choroideremia. Of these, the images of 49 eyes were suitable for alignment. Twenty-nine eyes were excluded from the analysis for the following reasons: (1) no outer retina remaining on OCT (due to end stage degeneration, *n* = 15), (2) poor image quality (due to poor fixation, *n* = 8), and (3) intact outer retina extending beyond the edge of captured image (usually in early disease, *n* = 6) ([Table](#i1552-5783-57-8-3674-t01){ref-type="table"}). When the transfoveal AF island widths (*y*) measured on AF images were compared with those predicted (*y\'*) based on the width of intact ONL on OCT (*x*) in all 49 eyes (see schematic illustration in [Fig. 1](#i1552-5783-57-8-3674-f01){ref-type="fig"}D), the median difference was zero (range, −65 to +62 μm). In 29 (59%) eyes, an exact correspondence was found between the predicted and measured transfoveal AF island width. The overall Spearman rank correlation coefficient (rho) between measured and predicted transfoveal AF width was 0.9992. The external limiting membrane (ELM) and the ellipsoid zone (EZ) generally terminated at the same location as where the ONL thickness began to show a sharp decline.^[@i1552-5783-57-8-3674-b03]^ The EZ and ELM were often ill defined at the edge of degeneration due to a disrupted appearance on the OCT, and were less reliable predictors of the location of the AF border.

![Correlation between edges of AF islands and OCT structural changes in choroideremia. Panels (**A**--**C**) show representative images from three choroideremia patients. By plotting pairs of intersecting *circles* of proportional diameters from fixed reference points (e.g., vessel branch points) on the AF and SLO images, precisely corresponding point locations could be identified between the AF and OCT B-scans, and vice versa. The intersection between two *red circles* on the AF image marking the left-hand border of RPE degeneration (**A*****i***), with high magnification view shown (**A*****ii***), corresponds to the position on the OCT indicated by a *vertical red line* (**A*****iv***), while the intersection between green circles marking the right-hand border of RPE degeneration (**A*****i***, **A*****iii***) corresponds to a second position on the OCT indicated by a *vertical green line* (**A*****v***). The same applies to panels (**B**, **C**). The edges of surviving RPE on the OCT coincide with the start of an acute decline in ONL height, which diminishes to zero in a triangular transition zone, denoted by *horizontal yellow bars*. Immediately beyond the loss of ONL, outer retinal tubulations were frequently observed (*yellow arrows*). *Scale bars*: 200 μm. A summary of the characteristic OCT to AF image alignment features is provided in (**D**). Correlation between the transfoveal island width (*y*) measured on AF images and those predicted based on OCT outer retinal width (*x*) was performed in 49 choroideremia eyes (data summarized in the [Table](#i1552-5783-57-8-3674-t01){ref-type="table"}). OPL, outer plexiform layer; BM, Bruch\'s membrane.](i1552-5783-57-8-3674-f01){#i1552-5783-57-8-3674-f01}

###### 

Choroideremia Patient Data

![](i1552-5783-57-8-3674-t01)

In six eyes of three patients aged 16, 22, and 23 years, the residual AF islands consisted of an ovoid central zone of relatively preserved AF and a peripheral zone of mottled AF ([Fig. 2](#i1552-5783-57-8-3674-f02){ref-type="fig"}). When these AF images were aligned to their respective OCTs, the regions with preserved AF were found to correspond to areas of the retina with preserved EZ integrity, while the surrounding region of mottled AF corresponded to areas with disrupted EZ. The horizontal diameters of the central ovoid zones with preserved AF were individual-specific but non--age-dependent: 3050 μm OD/3180 μm OS (age 16), 3250 μm OD/3050 μm OS (age 22), and 2400 μm OD/2400 μm OS (age 23). The mean eccentricities of the zones of preserved AF in relation to the anatomic foveal dip were 1533 μm (SEM = 179) nasally, 1339 (SEM = 157) temporally, and 1436 (SEM = 70) overall, which are consistent with these zones representing areas of relatively high cone density.^[@i1552-5783-57-8-3674-b04],[@i1552-5783-57-8-3674-b05]^ While such AF zonal transition was seen in three of the youngest choroideremia patients in the cohort (presumably a phenotype associated with an early stage of disease), the rest of the eyes presented with more homogeneous mottled AF over the entire island, associated with generalized EZ disruption.

![Correlation between the pattern of AF and integrity of the EZ. In three young choroideremia patients aged 16 (**A**), 22 (**B**), and 23 years (**C**) who have large residual islands remaining on AF imaging, central ovoid zones with relatively preserved AF were observed, which aligned with regions of preserved EZ integrity on the OCT (*green arrow bars*). The size and eccentricities of these ovoid zones in relation to the anatomical foveal dip (*white arrows*) are consistent with representing areas of greatest cone density.^[@i1552-5783-57-8-3674-b04],[@i1552-5783-57-8-3674-b05]^ The rest of the islands showed mottled AF, which corresponded to disrupted EZ (*yellow arrow bars*). Areas of absent AF corresponded to complete EZ loss (*red arrow bars*). Note that in (**A**) (OD & OS) and (**C**) (OS), at least one edge of the AF island fell outside the OCT image boundaries, therefore the foveola has been used as one of the reference points during image alignment.](i1552-5783-57-8-3674-f02){#i1552-5783-57-8-3674-f02}

Tubulations and the Effects of Gene Therapy {#s3b}
-------------------------------------------

Outer retinal tubulations (ORT) have previously been observed in advanced AMD and other degenerative retinal conditions.^[@i1552-5783-57-8-3674-b06]^ The mechanism of tubule formation is unclear, although it has been speculated to represent an arrangement of degenerating photoreceptors with potential contribution from adjacent RPE or glial elements. In our cohort of choroideremia patients, tubulations were found to be present to a variable extent on the OCT of the majority of eyes across the age range and disease severity ([Fig. 3](#i1552-5783-57-8-3674-f03){ref-type="fig"}): 71 of 78 (91%) eyes examined demonstrated tubulations; one eye was not assessable due to poor image quality ([Table](#i1552-5783-57-8-3674-t01){ref-type="table"}). The six eyes that did not show any tubulations were all at end-stage degeneration with no outer retinal structure remaining. When mapped onto AF images, the tubulations seen on OCT B-scans were universally located beyond the edges of the AF islands (therefore, overlying bare Bruch\'s membrane), with a mean distance of approximately 400 to 500 μm from the nearest island edge, although some were significantly farther away ([Fig. 3](#i1552-5783-57-8-3674-f03){ref-type="fig"}D). Even though tubulations appear to be isolated and cystic in appearance on OCT B-scans, two-dimensional analysis of their locations showed that many were in fact contiguous with the main island of surviving outer retina via 'pseudodendritic\' tubular extensions ([Fig. 4](#i1552-5783-57-8-3674-f04){ref-type="fig"}). These thin pseudodendrites appear to lie over areas devoid of RPE (by the absence of AF) but are detectable by their retinal pigmentation on high magnification infrared SLO images.

![Distribution of outer retinal cysts in six patients with choroideremia aged 16 to 71 years (\[**A**--**F**\] in ascending age order). The distribution of tubulations could be inferred from the positions of all outer retinal cysts (ORCs), which represent cross-sections of tubulations, seen on all B-scans of the OCT. For each eye, all ORCs were mapped to corresponding locations on the AF image (shown as *white dots*). The [Table](#i1552-5783-57-8-3674-t01){ref-type="table"} displays the mean distance of ORCs from the nearest edge of AF island (±SD) and genetic mutations in the *CHM* gene for each patient.](i1552-5783-57-8-3674-f03){#i1552-5783-57-8-3674-f03}

![Outer retinal cysts on OCT represent cross-sections through outer retinal tubulations following RPE loss at the edges of degeneration. Plotting the locations of ORCs (*white dots*) seen on every B-scan of the OCT (*horizontal green lines*) over the corresponding high magnification infrared SLO image revealed that the ORCs lie over thin 'pseudodendrites\' containing retinal pigment along the edges of the surviving retina (outlined in *dotted blue*). These pseudodendrites do not match the background autofluorescence of the choroidal vasculature (*top panel*) but represent distinct tubular outer retinal structures.](i1552-5783-57-8-3674-f04){#i1552-5783-57-8-3674-f04}

Because tubulations likely represent rearrangement of surviving photoreceptors, we asked whether their distribution would be affected by subretinal injections in gene therapy, because this would provide us with indirect evidence as to whether or not they might have retained synapses to the overlying retina. When the locations of tubulations were compared between baseline, 1 month, and 6 months post AAV.REP1 gene therapy, it could be seen that the general distributions of tubulations were not significantly affected by surgically induced retinal detachments ([Fig. 5](#i1552-5783-57-8-3674-f05){ref-type="fig"}). Moreover, while a slight dip in the number of outer retinal cysts seen in some eyes at 1 month could be attributed to mechanical disturbance from the retinal detachment, there was no statistically significant fluctuation over the 6-month period (linear regression: *F*(5,6) = 1.29, *P* = 0.38; [Supplementary Fig. S1](#i1552-5783-57-8-3674-s01){ref-type="supplementary-material"}). These would be in keeping with tubulations maintaining some physical attachment to the inner retina, thereby potentially retaining some visual function over these anatomical anomalies.

![The effects of subretinal gene therapy on outer retinal tubulations. Gene therapy using recombinant AAV2-REP1 vector for choroideremia were performed on six eyes (**A**--**F**) in which the residual AF islands were surgically detached by subretinal injections. The locations of outer retinal cysts (*white dots*) seen on all B-scans of the OCTs, which represent cross-sections of tubulations, have been mapped onto the corresponding AF images at baseline (*left column*), 1 month post (*center column*) and 6 months post (*right column*) gene therapy.](i1552-5783-57-8-3674-f05){#i1552-5783-57-8-3674-f05}

Correlation Between Choroidal Thickness and Ellipsoid Zone {#s3c}
----------------------------------------------------------

Although the *CHM* gene defect is known to cause degeneration, most patients start life with good vision. We were therefore interested to know if there might be any developmental anomalies in choroideremia patients and/or if the subfoveal choroid thinning begins before significant foveal retinal degeneration is evident. Subfoveal choroidal thickness was measured in 42 eyes of 23 choroideremia patients (mean age 37.5 years; range, 12--63) and 40 eyes of 20 age-matched healthy male controls (mean age 37.6 years; range, 13--62; [Supplementary Table S1](#i1552-5783-57-8-3674-s01){ref-type="supplementary-material"}). The mean refraction of CHM eyes was −0.92 D (±SEM 0.37) and control eyes −0.28 D (±SEM 0.34). Unpaired 2-tailed *t*-test showed no statistically significant difference between the refractions of the two groups (*P* = 0.21). The mean SFCT in healthy controls (302.0 μm ± 4.8 SEM) was found to be significantly greater than that in CHM eyes with preserved EZ (179.7 μm ± 17.2 SEM; *P* \< 0.0001; [Fig. 6](#i1552-5783-57-8-3674-f06){ref-type="fig"}). Also, the SFCT of CHM eyes with disrupted EZ (191.9 μm ± 10.8 SEM) was significantly greater than those with lost EZ (43.1 μm ± 6.5 SEM; *P* \< 0.0001). However, no significant difference in SFCT was found between CHM eyes associated with preserved and disrupted EZ (*P* = 0.8251).

![Scatter plot of SFCT as measured on enhanced-depth OCT in choroideremia patients with preserved, disrupted or lost ellipsoid zone (as illustrated by representative OCT images above) versus age and refractive error-matched healthy controls. The mean of each group (in *black*) is shown with 1 SD on either side (in *gray*). Intergroup statistical comparisons were performed using Kruskal-Wallis test with *P* values shown. See raw data in [Supplementary Table S1](#i1552-5783-57-8-3674-s01){ref-type="supplementary-material"}.](i1552-5783-57-8-3674-f06){#i1552-5783-57-8-3674-f06}

Discussion {#s4}
==========

The *CHM* gene product, REP1 (Rab escort protein 1), regulates the prenylation of Rab GTPases, which play important roles in intracellular vesicular trafficking. Deficiency of REP1 is thought to impair the transport of proteins from the Golgi apparatus to the outer segments in photoreceptors, as well as the phagocytosis and degradation of shed outer segments by RPE cells. Cell type-specific knockouts of *Chm* in mice have shown the potential for independent degeneration of photoreceptor and RPE layers, but the rate of degeneration was accelerated when both layers were defective simultaneously, presumably due to interdependent cell survival.^[@i1552-5783-57-8-3674-b07],[@i1552-5783-57-8-3674-b08]^ Our data revealed a precise anatomical correspondence between RPE and photoreceptor degeneration: the edge of RPE loss colocalized with a sharp decline in ONL thickness in the majority of eyes with CHM. Small sporadic discrepancies were occasionally observed, which were equivalent to the size of fewer than four RPE cells each with a diameter of approximately 15 μm.^[@i1552-5783-57-8-3674-b09]^ These could be attributed, in part, to temperature and calibration-dependent alignment errors between simultaneous infrared and tomographic scans from the Heidelberg Spectralis system itself.^[@i1552-5783-57-8-3674-b10]^ In the narrow transition zone between intact and degenerate outer retina, the ONL was consistently seen to taper in a triangular fashion, a feature that has previously been termed an 'interlaminar bridge\'.^[@i1552-5783-57-8-3674-b11],[@i1552-5783-57-8-3674-b12]^ We hypothesize that this transition zone represents degenerating photoreceptors that reduce in height as they lose outer segments following the death of the interdigitating RPE cells, eventually leading to cell death. This would be in keeping with histopathologic observations from postmortem female carriers of choroideremia.^[@i1552-5783-57-8-3674-b13]^

The correlation between RPE and photoreceptor integrity was not only observed at the advancing border of degeneration, but also within the islands of surviving outer retina/RPE. Ovoid zones of parafoveal preservation of AF were seen in some of the youngest choroideremia patients in the cohort, which correlated with transitions in the integrity of the EZ. Moreover, the size and eccentricities of the ovoid zones were consistent with representing areas of relatively high cone density previously observed using histology and adaptive optics.^[@i1552-5783-57-8-3674-b04],[@i1552-5783-57-8-3674-b05]^ Taken together, the data provides indirect evidence for relative sparing of cones (and their underlying RPE) in the early stages of choroideremia. The early cone sparing may be explained by the low REP1 expression in cones versus high expression in rods.^[@i1552-5783-57-8-3674-b05],[@i1552-5783-57-8-3674-b12]^ As the disease progresses, the central preservation is lost, suggesting that cone degeneration in choroideremia may be secondary to rod or RPE degeneration. It would also explain the clinical finding of early-onset nyctalopia, but preservation of visual acuity and color perception until late stage degeneration in choroideremia patients.

We found no significant difference between the subfoveal choroidal thickness underlying retina with preserved or disrupted EZ. The choroidal thickness only dropped once the EZ has completely degenerated. This suggests that choroidal degeneration may be a secondary phenomenon, which lags significantly behind photoreceptor (and RPE) degeneration. This would be in keeping with observations from postmortem female carriers in which choroidal thinning was only seen in areas of severe retinal degeneration.^[@i1552-5783-57-8-3674-b13]^ We noted, however, that SFCT was reduced in early choroideremia eyes compared with controls, at a time when the EZ remained relatively intact. Although choroidal thickness is affected by age, sex, and refractive error, these factors were all similar between the CHM and control eyes in the study.^[@i1552-5783-57-8-3674-b14]^ A possible explanation would be that the impairment of RPE due to REP1 deficiency also impairs the ability of the RPE to influence development of the choroidal vasculature long before the onset of degeneration. Alternatively, REP1 deficiency may be associated with a primary choroidal abnormality, although this is unlikely based on two observations: (1) CHM carrier females with patchy retinal degeneration due to X-inactivation do not show corresponding patchy choroidal abnormality, and (2) CHM patients occasionally present with secondary choroidal neovascularization, which suggests relatively intact choroidal angiogenesis. Nevertheless the reduced choroidal thickness at baseline did not appear to have any obvious effect on visual acuity in the early stages of the disease. Choroidal thinning has also been described as a secondary phenomenon in dry AMD, presumably as a result of degeneration of the RPE.^[@i1552-5783-57-8-3674-b15]^ Hence, choroidal thinning in CHM appears to occur through a dual mechanism of reduced baseline thickness, which is probably not clinically significant, but which then progresses once there is loss of the overlying RPE as part of the late disease process.

Not all photoreceptors are lost beyond the edge of RPE degeneration, as some appear to survive by forming outer retinal tubulations, which could extend a considerable distance from the main surviving outer retinal island. We found tubulations in the majority of choroideremia eyes, except those with near total outer retinal loss. While they appear cystic on OCT B-scans, mapping their locations to high magnification SLO images showed that they most likely represent cross-sections through long tubular structures jutting out from the edges of outer retinal degeneration. Tubulations have been described in a range of degenerative retinal disorders, including AMD, Stargardt disease, central serous retinopathy, serpiginous choroiditis, maternally inherited diabetes and deafness, gyrate atrophy, and choroideremia.^[@i1552-5783-57-8-3674-b06],[@i1552-5783-57-8-3674-b13],[@i1552-5783-57-8-3674-b16][@i1552-5783-57-8-3674-b17][@i1552-5783-57-8-3674-b18][@i1552-5783-57-8-3674-b19][@i1552-5783-57-8-3674-b20]--[@i1552-5783-57-8-3674-b21]^ They likely represent rearrangement of photoreceptors that have lost their outer segments following the degeneration of the underlying RPE cells, but are still close enough to the residual choroid to derive oxygenation and other diffusible substrates required for metabolic survival. This would be consistent with RPE degeneration being a key feature of all the conditions above. The fact that tubulations represent residual photoreceptors is in keeping with histologic analysis of tubulations in advanced AMD, which showed cones lacking outer segments.^[@i1552-5783-57-8-3674-b22]^ Apart from a slight dip in the total number of outer retinal cysts at 1 month post gene therapy (likely due to physical disturbance from the surgical retinal detachment), the overall numbers and distributions of tubulations were stable over a 6-month period. While this does not completely exclude the possibility of some tubulations disappearing and forming at similar locations, the data provide indirect evidence that tubulations represent stable outer retinal structures, which retain some physical attachment to the retina, rather than being inflammatory in origin.^[@i1552-5783-57-8-3674-b23]^ The preservation of tubulations following gene therapy could also be an indication that the surgery did not cause significant disruption of outer retinal integrity, a concern due to possible stretching of the retina during subretinal injection. Because tubulations lie over bare Bruch\'s membrane and are often contiguous with the main retinal island, one might expect retinal detachment to be induced with greater ease at these locations compared with more adherent degenerative retina elsewhere. What remains to be seen, however, is whether or not visual function can be restored in these tubulations following gene therapy and more importantly, whether or not this represents a degree of degeneration in choroideremia that may be arrested.

Supplementary Material
======================
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Click here for additional data file.

The data has been presented as a poster at the Oxford Ophthalmological Congress, Oxford, United Kingdom (5--8 July 2015).
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